1. The synthesis of [14C]AZD5122. Incorporation of an IV 14C‐microtracer dose into a first in human study to determine the absolute oral bioavailability of AZD5122. (12th May 2016) Authors: Hickey, Michael J.; Allen, Paul H.; Kingston, Lee P.; Wilkinson, David J. Other Names: Maxwell Brad D. guestEditor.; Elmore Charles S. guestEditor. Journal: Journal of labelled compounds & radiopharmaceuticals Issue: Volume 59:Number 6(2016) Page Start: 245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Syntheses of a radiolabelled CXCR2 antagonist AZD5069 and its major human metabolite. (27th July 2016) Authors: Hickey, Michael J.; Allen, Paul H.; Caffrey, Moya; Hansen, Peter; Kingston, Lee P.; Wilkinson, David J. Journal: Journal of labelled compounds & radiopharmaceuticals Issue: Volume 59:Number 11(2016) Page Start: 432 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A short expedient synthesis of [14C]Ticlopidine. (27th January 2014) Authors: Hickey, Michael J.; Kingston, Lee P.; Allen, Paul H.; Johnson, Tim; Wilkinson, David J. Journal: Journal of labelled compounds & radiopharmaceuticals Issue: Volume 57:Number 3(2014) Page Start: 172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗